Arkolith/Insider Trading/DRMA/Form 4

Scott Kathleen D.

DirectorDermata Therapeutics, Inc. (DRMA) · full profile →Form 4 · filed Jun 16, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$13
Net Open-Market Flow
-$13
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 16, 2026Sell(S)11$1.19$130

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-26-028884) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML